Paradigm Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Sell |
7,300
-9,100
| -55% | -$1.96M | 0.39% | 82 |
|
|
2026
Q1 | $3.57M | Hold |
16,400
| – | – | 0.84% | 13 |
|
|
2025
Q4 | $3.75M | Sell |
16,400
-1,100
| -6% | -$251K | 0.87% | 13 |
|
|
2025
Q3 | $4.05M | Hold |
17,500
| – | – | 0.93% | 12 |
|
|
2025
Q2 | $3.25M | Buy |
17,500
+3,100
| +22% | +$576K | 0.8% | 15 |
|
|
2025
Q1 | $3.02M | Hold |
14,400
| – | – | 0.8% | 18 |
|
|
2024
Q4 | $2.56M | Buy |
14,400
+2,200
| +18% | +$404K | 0.7% | 28 |
|
|
2024
Q3 | $2.41M | Hold |
12,200
| – | – | 0.63% | 24 |
|
|
2024
Q2 | $2.09M | Sell |
12,200
-9,750
| -44% | -$1.62M | 0.58% | 31 |
|
|
2024
Q1 | $4M | Sell |
21,950
-550
| -2% | -$94.8K | 1.02% | 7 |
|
|
2023
Q4 | $3.49M | Sell |
22,500
-600
| -3% | -$87.5K | 0.92% | 9 |
|
|
2023
Q3 | $3.44M | Sell |
23,100
-1,300
| -5% | -$191K | 0.98% | 7 |
|
|
2023
Q2 | $3.29M | Buy |
24,400
+7,900
| +48% | +$1.16M | 0.88% | 12 |
|
|
2023
Q1 | $2.63M | Hold |
16,500
| – | – | 0.72% | 19 |
|
|
2022
Q4 | $2.67M | Buy |
16,500
+12,300
| +293% | +$1.89M | 0.75% | 18 |
|
|
2022
Q3 | $564K | Sell |
4,200
-700
| -14% | -$100K | 0.19% | 210 |
|
|
2022
Q2 | $750K | Buy |
+4,900
| New | +$749K | 0.23% | 175 |
|
|
2020
Q4 | – | Sell |
-8,350
| Closed | -$731K | – | 322 |
|
|
2020
Q3 | $731K | Hold |
8,350
| – | – | 0.23% | 191 |
|
|
2020
Q2 | $820K | Buy |
8,350
+6,900
| +476% | +$608K | 0.25% | 150 |
|
|
2020
Q1 | $110K | Hold |
1,450
| – | – | 0.04% | 285 |
|
|
2019
Q4 | $128K | Buy |
1,450
+200
| +16% | +$16.6K | 0.04% | 290 |
|
|
2019
Q3 | $94.7K | Hold |
1,250
| – | – | 0.03% | 329 |
|
|
2019
Q2 | $90.9K | Sell |
1,250
-7,950
| -86% | -$625K | 0.03% | 346 |
|
|
2019
Q1 | $741K | Sell |
9,200
-800
| -8% | -$65.4K | 0.22% | 159 |
|
|
2018
Q4 | $922K | Sell |
10,000
-900
| -8% | -$79.1K | 0.3% | 121 |
|
|
2018
Q3 | $1.03M | Sell |
10,900
-11,800
| -52% | -$1.12M | 0.29% | 118 |
|
|
2018
Q2 | $2.1M | Hold |
22,700
| – | – | 0.61% | 62 |
|
|
2018
Q1 | $2.15M | Sell |
22,700
-1,200
| -5% | -$132K | 0.62% | 64 |
|
|
2017
Q4 | $2.31M | Buy |
+23,900
| New | +$2.25M | 0.63% | 64 |
|
|
2017
Q2 | – | Sell |
-9,360
| Closed | -$610K | – | 585 |
|
|
2017
Q1 | $610K | Sell |
9,360
-1,890
| -17% | -$119K | 0.12% | 219 |
|
|
2016
Q4 | $704K | Buy |
+11,250
| New | +$687K | 0.14% | 143 |
|
|
2016
Q2 | – | Sell |
-1,151
| Closed | -$65.7K | – | 778 |
|
|
2016
Q1 | $65.7K | Buy |
1,151
+51
| +5% | +$2.84K | 0.01% | 536 |
|
|
2015
Q4 | $65.2K | Sell |
1,100
-88,254
| -99% | -$5.08M | 0.01% | 574 |
|
|
2015
Q3 | $4.86M | Sell |
89,354
-8,100
| -8% | -$527K | 0.64% | 47 |
|
|
2015
Q2 | $6.55M | Buy |
97,454
+1,000
| +1% | +$65.3K | 0.73% | 20 |
|
|
2015
Q1 | $5.65M | Buy |
96,454
+86,500
| +869% | +$5.23M | 0.63% | 54 |
|
|
2014
Q4 | $651K | Sell |
9,954
-61,500
| -86% | -$3.88M | 0.08% | 257 |
|
|
2014
Q3 | $4.13M | Sell |
71,454
-700
| -1% | -$38.9K | 0.58% | 53 |
|
|
2014
Q2 | $4.07M | Sell |
72,154
-6,300
| -8% | -$331K | 0.55% | 55 |
|
|
2014
Q1 | $4.03M | Buy |
78,454
+16,500
| +27% | +$834K | 0.55% | 55 |
|
|
2013
Q4 | $3.27M | Buy |
61,954
+36,400
| +142% | +$1.79M | 0.5% | 55 |
|
|
2013
Q3 | $1.14M | Sell |
25,554
-1,900
| -7% | -$84.2K | 0.19% | 158 |
|
|
2013
Q2 | $1.13M | Buy |
+27,454
| New | +$1.2M | 0.19% | 159 |
|
Other funds holding ABBV
Paradigm Asset Management's ABBV Position: Q2 2026 in Review
Paradigm Asset Management reduced its AbbVie (ABBV) stake by 55% in Q2 2026, selling an estimated $1.96M and leaving 7,300 shares worth $1.84M. The position accounts for 0.39% of the portfolio, ranked #82.
Paradigm Asset Management first reported a position in ABBV in Q2 2013 and has held it in 43 quarters since. The position peaked at $6.55M in Q2 2015. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Paradigm Asset Management held 7,300 shares of AbbVie worth $1.84M as of Q2 2026.
- Paradigm Asset Management sold 9,100 AbbVie shares in Q2 2026, an estimated $1.96M.
- AbbVie made up 0.39% of Paradigm Asset Management's portfolio in Q2 2026, its #82 holding.
- Paradigm Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 43 quarters since.
- Paradigm Asset Management's AbbVie position peaked at $6.55M in Q2 2015.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Paradigm Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.